BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32784300)

  • 1. Urachal Cancer in Germany and the USA: An RKI/SEER Population-Based Comparison Study.
    Hager T; Kraywinkel K; Szarvas T; Hadaschik B; Schmid KW; Reis H
    Urol Int; 2020; 104(9-10):803-809. PubMed ID: 32784300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
    Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
    BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade mucinous neoplasms (LAMN) of the appendix in Germany between 2011 and 2018: a nationwide analysis based on data provided by the German Center for Cancer Registry Data (ZfKD) at the Robert Koch Institute (RKI).
    Köhler F; Reese L; Hendricks A; Kastner C; Müller S; Lock JF; Germer CT; Wiegering A
    Langenbecks Arch Surg; 2022 Dec; 407(8):3615-3622. PubMed ID: 35962281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies.
    Olah C; Kubik A; Mátrai P; Engh MA; Barna V; Hegyi P; Reis H; Nyirády P; Szarvas T
    Urol Oncol; 2024 Jul; 42(7):221.e1-221.e7. PubMed ID: 38627107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
    Sirri E; Kieschke J; Vohmann C; Katalinic A; Nennecke A; Ressing M; Eberle A; Holleczek B; Jansen L; Brenner H;
    Int J Cancer; 2020 Sep; 147(6):1548-1558. PubMed ID: 32072636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
    Schulz GB; Grimm T; Buchner A; Jokisch F; Kretschmer A; Stief CG; Knüchel R; Kraywinkel K; Karl A
    Clin Genitourin Cancer; 2020 Jun; 18(3):162-170.e4. PubMed ID: 31956010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
    Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
    Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.
    Sirri E; Castro FA; Kieschke J; Jansen L; Emrich K; Gondos A; Holleczek B; Katalinic A; Urbschat I; Vohmann C; Brenner H
    Pancreas; 2016 Jul; 45(6):908-14. PubMed ID: 26745860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
    Reis H; Krafft U; Niedworok C; Módos O; Herold T; Behrendt M; Al-Ahmadie H; Hadaschik B; Nyirady P; Szarvas T
    Dis Markers; 2018; 2018():7308168. PubMed ID: 29721106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site.
    Jansen L; Buttmann-Schweiger N; Listl S; Ressing M; Holleczek B; Katalinic A; Luttmann S; Kraywinkel K; Brenner H;
    Oral Oncol; 2018 Jan; 76():8-15. PubMed ID: 29290288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.
    Hager B; Kraywinkel K; Keck B; Katalinic A; Meyer M; Zeissig SR; Scheufele R; Wirth MP; Huber J
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):61-66. PubMed ID: 27618951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
    Katalinic A; Kunze U; Schäfer T
    Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival from common and rare cancers in Germany in the early 21st century.
    Hiripi E; Gondos A; Emrich K; Holleczek B; Katalinic A; Luttmann S; Sirri E; Brenner H;
    Ann Oncol; 2012 Feb; 23(2):472-9. PubMed ID: 21597096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study.
    Natale C; Leinwand GZ; Chiang J; Silberstein JL; Krane LS
    Clin Genitourin Cancer; 2019 Oct; 17(5):380-388. PubMed ID: 31395362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of malignant urachal tumor: A hospital-based cancer registry data in Japan.
    Nagumo Y; Kojima T; Shiga M; Kojo K; Tanaka K; Kandori S; Kimura T; Kawahara T; Kawai K; Okuyama A; Higashi T; Nishiyama H
    Int J Urol; 2020 Feb; 27(2):157-162. PubMed ID: 31793080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.